Effects of Vitamin D and Omega-3 Fatty Acids Co-Supplementation on Inflammatory Factors and Tumor Marker CEA in Colorectal Cancer Patients Undergoing Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- 5 September 2019
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 72 (6) , 948-958
Abstract
Objectives: This study aimed to investigate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory factors and tumor marker CEA in colorectal cancer patients undergoing chemotherapy. Methods: In this study, 81 patients with stage ӀӀ or ӀӀӀ colorectal cancer were randomly assigned into four groups: (1) control: receiving a vitamin D placebo, weekly + two omega-3 fatty acid placebo capsules, daily; (2) omega-3 fatty acid, receiving two omega-3 fatty acid capsules (each capsule containing 330 mg of omega-3 fatty acids), daily + a vitamin D placebo, weekly; (3) vitamin D, receiving a 50,000 IU vitamin D soft gel, weekly + two omega-3 fatty acid placebo capsules, daily; (4) co-supplementation, receiving a 50,000 IU vitamin D soft gel, weekly + two omega-3 fatty acids capsules, for 8 weeks. Before and after the intervention, serum levels of 25(OH)D, TNF-α, IL-1β, IL-6, IL-8, NF-kB activity, and tumor marker CEA, were measured. Results: After 8 weeks of intervention, patients who received combined vitamin D and omega-3 fatty acids supplements compared with omega-3, vitamin D, and placebo had significantly decreased TNF-α, and IL-1β (P < .05). In addition, serum levels of TNF-α, IL-1β, IL-6, IL-8, and tumor marker CEA were decreased significantly in omega-3, vitamin D, and co-supplementation of them, compared with baseline. NF-kB activity was decreased significantly in vitamin D and co-supplementation groups, compared with baseline. Regarding CEA, there was no significant difference between the four groups at the end of intervention (P > .05). Conclusion: Results show that co-supplementation of vitamin D and omega-3 fatty acids co-supplementation, in colorectal cancer patients have beneficial impacts on inflammation and tumor marker CEA.This publication has 56 references indexed in Scilit:
- CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapyJournal of Surgical Oncology, 2017
- Apoptosis-Mediated Chemoprevention by Different Ratios of Fish Oil in Experimental Colon CarcinogenesisCancer Investigation, 2016
- Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancerJournal of Experimental & Clinical Cancer Research, 2015
- Fish Oil Supplement Alters Markers of Inflammatory and Nutritional Status in Colorectal Cancer PatientsNutrition and Cancer, 2012
- Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compoundsMolecular Nutrition & Food Research, 2010
- Novel Gemini vitamin D3 analogs have potent antitumor activityThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Multi-targeted therapy of cancer by omega-3 fatty acidsCancer Letters, 2008
- Epidemiology, disease Progression, and Economic Burden of Colorectal CancerJournal of Managed Care Pharmacy, 2007
- Docosahexaenoic Acid (DHA), a Primary Tumor Suppressive Omega-3 Fatty Acid, Inhibits Growth of Colorectal Cancer Independent of p53 Mutational StatusNutrition and Cancer, 2007
- Omega-3 Fatty Acids to Augment Cancer TherapyThe Journal of Nutrition, 2002